• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Sevelamer Taro 800 mg
    / Taro

    Active Ingredient
    Sevelamer Carbonate anhydrous 800 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    160 X 800 mg

    not in the basket chart 54683


    Starting dose: The recommended starting dose of sevelamer carbonate is 2.4 g or 4.8 g per day based on clinical needs and serum phosphorus level.
    Please refer to the license holder for further details. 

    recommended drugs


    For the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.Also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ≥ 1.78 mmol/l.Should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.


    Hypersensitivity to the active substance or to any of the excipients. Hypophosphataemia. Bowel obstruction.

    Special Precautions

    Intestinal obstruction and ileus/subileus. Low levels of fat-soluble vitamins A, D, E and K. Hypocalcaemia or hypercalcaemia. Metabolic acidosis. Peritonitis.

    Pharmaceutical Works Polpharma S.A., Poland